D. E. Shaw & Co. LP recently announced the acquisition of new stake in Dillard’s Inc. (NYSE:DDS). The institutional investor has increased its shareholding in the Consumer Cyclical company by 27.29% to 0.15 million shares with purchase of 31370.0 shares. This fresh investment now brings its stake to 1.11% valued currently at $47.29 million. In addition, Pacific Investment Management Co raised its holdings by 33622.0 to 99903.0 shares.
With over 0.14 million Dillard’s Inc. (DDS) shares trading Friday and a closing price of $367.01 on the day, the dollar volume was approximately $50.66 million. The shares have shown a positive half year performance of 67.18% and its price on 01/20/23 lost nearly -1.57%. Currently, there are 17.14M common shares owned by the public and among those 9.13M shares have been available to trade.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 4 analysts who have offered their price forecasts for DDS have a consensus price objective of $291.67. The analysts have set the share’s price value over the next 12 months at a high of $380.00 and a low of $150.00. The average price target is -38.49% below its recent price level and a downside to the estimated low will see the stock lose -144.67% over that period. But an upside of 3.42% will see the stock hit the forecast high price target while median target price for the stock is $345.00.
Insiders at the company have transacted a total of 44 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 40 of these insider trades were purchases, accounting for 29,501 shares. Insider sales of the common stock occurred on 4 occasions, with total insider shares sold totaling 6,300 shares.
The top 3 mutual fund holders in Dillard’s Inc. are DFA US Small Cap Value Portfolio, DFA US Targeted Value Portfolio, and Dimensional US Targeted Value ETF. DFA US Small Cap Value Portfolio owns 0.28 million shares of the company’s stock, all valued at over $89.59 million. The company sold 1152.0 shares recently to bring their total holdings to about 2.11% of the shares outstanding. DFA US Targeted Value Portfolio sold 15473.0 shares to see its total holdings shrink to 0.17 million shares valued at over $53.7 million and representing 1.26% of the shares outstanding. Dimensional US Targeted Value ETF now owns shares totaling to 1.12% of the shares outstanding.
Shares of Dillard’s Inc. (NYSE: DDS) opened at $372.90, up $0.05 from a prior closing price of $372.85. However, the script later moved the day high at 372.90, down -1.57%. The company’s stock has a 5-day price change of 0.42% and 27.01% over the past three months. DDS shares are trading 13.56% year to date (YTD), with the 12-month market performance up to 58.93% higher. It has a 12-month low price of $184.14 and touched a high of $385.88 over the same period. DDS has an average intraday trading volume of 148.41K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 9.36%, 9.85%, and 29.03% respectively.
Institutional ownership of Dillard’s Inc. (NYSE: DDS) shares accounts for 74.70% of the company’s 17.14M shares outstanding. Mutual fund holders own 54.33%, while other institutional holders and individual stakeholders account for 55.70% and 18.76% respectively.
It has a market capitalization of $6.39B and a beta (3y monthly) value of 0.84. The stock’s trailing 12-month PE ratio is 7.26, while the earnings-per-share (ttm) stands at $50.55. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.31% over the week and 3.70% over the month.
Analysts forecast that Dillard’s Inc. (DDS) will achieve an EPS of $4.96 for the current quarter, $8.49 for the next quarter and $23.97 for 2024. The lowest estimate earnings-per-share for the quarter is $2.52 while analysts give the company a high EPS estimate of $7.6. Comparatively, EPS for the current quarter was $9.81 a year ago. Earnings per share for the fiscal year are expected to increase by 128.00%, and -42.60% over the next financial year.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 4 brokerage firm advisors rate Dillard’s Inc. (DDS) as a “Hold” at a consensus score of 3.20. Specifically, 0 Wall Street analysts polled rate the stock as a buy, while 3 of the 4 advise that investors “hold,” and 1 rated it as a “Sell.”
Looking at the support for the DDS, a number of firms have released research notes about the stock. JP Morgan stated their Neutral rating for the stock in a research note on August 15, 2022, with the firm’s price target at $210-$298. Telsey Advisory Group coverage for the Dillard’s Inc. (DDS) stock in a research note released on February 23, 2022 offered a Market Perform rating with a price target of $275. UBS was of a view on November 30, 2021 that the stock is Sell, while Telsey Advisory Group gave the stock Market Perform rating on May 14, 2021, issuing a price target of $80- $110. Telsey Advisory Group on their part issued Market Perform rating on February 23, 2021.
